Abstract
Since branded drug companies lose market shares and monopoly profits when competitors enter, innovators tend to prevent competition to extend their monopoly power. As Bennato and Valletti (2014: 83) claim in their paper, monopoly power is gained through patent protection. Correspondingly, it is especially in the interest of originator companies to keep their monopoly power by extending patent protection and detain competition.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer Fachmedien Wiesbaden GmbH
About this chapter
Cite this chapter
Lehnhausen, AK. (2017). Anticompetitive actions taken by one firm only. In: Studies on Competition and Antitrust Issues in the Pharmaceutical Industry. BestMasters. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-16551-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-658-16551-2_3
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-16550-5
Online ISBN: 978-3-658-16551-2
eBook Packages: Business and ManagementBusiness and Management (R0)